Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Events / Business / GuideAI Health Corp. Lists on Cboe Canada
Business stock listing

GuideAI Health Corp. Lists on Cboe Canada

Analysis based on 8 articles · First reported Jun 29, 2026 · Last updated Jun 29, 2026

Sentiment
60
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The listing of Alzai Health Corporation on Canada provides a new investment opportunity in the healthcare technology sector, particularly for investors interested in artificial intelligence applications in diagnostics. This event enhances the visibility and liquidity of Alzai Health Corporation shares, potentially attracting more capital for its growth and innovation. For Canada, it reinforces its position as a supportive exchange for high-growth, innovative companies, potentially attracting more listings in the future.

Healthcare Technology Financial Services
Event Summary

Alzai Health Corporation, a healthcare technology company utilizing artificial intelligence for early detection of vascular disease, has received final approval and commenced trading of its common shares on Canada under the ticker symbol 'GDAI' on June 29, 2026. This public listing is a significant milestone for Alzai Health Corporation, enabling it to scale its platform and expand access to advanced diagnostic technology. Raj Shah, CEO of Alzai Health Corporation, expressed enthusiasm for joining the Canada community. Joacim Wiklander, CEO of Canada, welcomed Alzai Health Corporation, highlighting its innovative work in AI and cardiovascular health as the kind of company Canadian public markets should support.

Entities Involved
stock
Alzai Health Corporation
Alzai Health Corporation has successfully listed its common shares on Canada, marking a significant milestone for the company as it gains access to public markets for capital formation and increased visibility. This listing is expected to support its mission of expanding access to advanced diagnostic technology.
Importance 100.0 Sentiment 70.0
cnt
Canada
Canada welcomed Alzai Health Corporation to its exchange, reinforcing its position as a platform for innovative, high-growth companies in emerging sectors. This listing contributes to Canada's diverse offerings and commitment to capital formation.
Importance 90.0 Sentiment 50.0
per
Raj Shah
Raj Shah, CEO of Alzai Health Corporation, expressed excitement about the company's public listing on Canada, highlighting it as an important milestone for scaling their platform and expanding access to diagnostic technology.
Importance 80.0 Sentiment 60.0
per
Joacim Wiklander
Joacim Wiklander, CEO of Canada, welcomed Alzai Health Corporation, emphasizing the exchange's support for innovative companies at the intersection of artificial intelligence and cardiovascular health.
Importance 70.0 Sentiment 50.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.